Eli Lilly holds the lead position in the weight management market right now. But Viking Therapeutics is working on a ...

Since then, supply has returned thanks to Lilly's investments in manufacturing and a move to also offer Zepbound, previously ...

In the closing of the recent trading day, Viking Therapeutics, Inc. (VKTX) stood at $33.54, denoting a -3.44% move from the preceding trading day.

Viking Therapeutics, Inc. (NASDAQ:VKTX) is one of the best healthcare stocks with the highest upside. Viking Therapeutics, ...

Viking’s newly announced 2027-28 deployment includes six ships operating winter itineraries in Europe. Nearly half of the ...

Pfizer has agreed to acquire Metsera, a company specializing in weight-loss medications, for $47.50 per share in cash, along ...

In the latest close session, Viking Therapeutics, Inc. (VKTX) was down 2.54% at $33.05. This move lagged the S&P 500's daily loss of 0.16%. Meanwhile, the Dow experienced a rise of 0.44%, and the ...

Eli Lilly (LLY), the world’s highest-valued pharmaceutical company by market capitalization, holds a leading position in the ...

Parc Astérix is once again celebrating the magic of Christmas during the Christmas holidays, from December 20, 2025, to ...

VKTX is likely to have headed into Q3 earnings with no product revenue, pipeline updates in focus and widening loss forecasts testing investor patience.

A pretty North Yorkshire town has so many charity shops that they've created a trail to help locals and visitors explore them ...